Wagner Kristie Ann 4
4 · Entasis Therapeutics Holdings Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Wagner Kristie Ann
VP, Principal Fin & Acct Off
Transactions
- Award
Common Stock
2022-02-24+10,000→ 80,500 total
Footnotes (1)
- [F1]This award vests in equal 1/4 increments over four years on the anniversary of the date of grant, subject to the reporting person's continued employment with the company.